Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Publisher： Karger

E-ISSN： 1423-0232|83|3|141-150

ISSN： 0030-2414

Source： Oncology, Vol.83, Iss.3, 2012-07, pp. : 141-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience

By  

Oncology Research and Treatment, Vol. 35, Iss. 12, 2012-10 ,pp. : 740-745

Karger

Access to resources Recommend Favorite

Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases

By  

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 146-152

Karger

Access to resources Recommend Favorite

Brain Metastases and Breast Cancer Subtypes

By  

Oncology Research and Treatment, Vol. 33, Iss. 4, 2010-03 ,pp. : 143-144

Karger

Access to resources Recommend Favorite

Topotecan Chemotherapy in Patients with Breast Cancer and Brain Metastases: Results of a Pilot Study

By  

Oncology Research and Treatment, Vol. 24, Iss. 3, 2001-07 ,pp. : 256-260

Karger

Access to resources Recommend Favorite

Treatment and Prognostic Factors in Primary Peritoneal Carcinoma: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)

By  

Oncology Research and Treatment, Vol. 37, Iss. 6, 2014-05 ,pp. : 332-338

Karger

Access to resources Recommend Favorite